NEUROMUSCULAR DISORDERS

Scope & Guideline

Pioneering research for better patient outcomes.

Introduction

Immerse yourself in the scholarly insights of NEUROMUSCULAR DISORDERS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0960-8966
PublisherPERGAMON-ELSEVIER SCIENCE LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1991 to 2024
AbbreviationNEUROMUSCULAR DISORD / Neuromusc. Disord.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTHE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND

Aims and Scopes

The journal "Neuromuscular Disorders" focuses on the comprehensive exploration of neuromuscular diseases, emphasizing cutting-edge research, clinical practices, and therapeutic advancements. Its scope includes a wide range of topics from genetic studies to treatment outcomes, aimed at enhancing understanding and management of these complex disorders.
  1. Genetic and Molecular Mechanisms:
    Research on the genetic underpinnings of neuromuscular disorders, including identification of novel mutations and understanding their phenotypic implications.
  2. Clinical Trials and Therapeutic Interventions:
    Investigation of new treatment modalities, including gene therapies, pharmacological interventions, and their efficacy in clinical settings.
  3. Diagnostic Approaches and Biomarkers:
    Development and validation of diagnostic tools and biomarkers for early detection and monitoring of neuromuscular diseases.
  4. Natural History Studies:
    Longitudinal studies that track disease progression, clinical features, and outcomes in diverse patient populations.
  5. Patient-Centered Research:
    Focus on quality of life, psychosocial aspects, and patient-reported outcomes to inform clinical practices and improve care.
  6. Multidisciplinary Approaches:
    Integration of various specialties such as genetics, neurology, rehabilitation, and psychosocial support to address the complex needs of patients.
The journal "Neuromuscular Disorders" has seen significant growth in various emerging research themes, reflecting the dynamic nature of the field and the need for innovative approaches to understanding and managing neuromuscular diseases.
  1. Gene Therapy and Advanced Therapeutics:
    A surge in publications regarding gene therapy approaches, including innovative strategies for delivering therapies and assessing their long-term effects.
  2. Patient-Centered Outcomes and Quality of Life:
    Increasing emphasis on studies that explore patient-reported outcomes, quality of life, and the psychosocial impact of neuromuscular disorders.
  3. Multimodal Imaging Techniques:
    The integration of advanced imaging modalities, such as MRI and ultrasound, to assess muscle structure and function, providing valuable insights into disease progression.
  4. Artificial Intelligence and Machine Learning:
    Emerging interest in applying AI and machine learning techniques to analyze clinical data and improve diagnostic accuracy and treatment efficacy.
  5. Natural History and Longitudinal Studies:
    Growing focus on comprehensive natural history studies that track disease progression over time, contributing to a better understanding of various neuromuscular disorders.
  6. Telemedicine and Remote Monitoring:
    The rise of telemedicine and digital health tools for monitoring patients with neuromuscular disorders, especially highlighted during the COVID-19 pandemic.

Declining or Waning

While "Neuromuscular Disorders" continues to evolve, certain themes have shown a decline in prominence over the recent years. This shift may reflect changes in research focus, advancements in treatment options, or evolving clinical priorities.
  1. Traditional Electrophysiology:
    The reliance on traditional electrophysiological studies has diminished as newer, more advanced diagnostic techniques, such as genetic testing and imaging, have gained prominence.
  2. Basic Science Research:
    There appears to be a decline in purely basic science research focused on muscle biology, as the journal increasingly emphasizes translational and clinical studies.
  3. Descriptive Epidemiological Studies:
    While still relevant, the frequency of purely descriptive studies on the epidemiology of neuromuscular disorders has decreased, with a shift towards studies that incorporate clinical outcomes and patient experiences.
  4. Animal Models in Early Research:
    The use of animal models for initial drug testing and understanding disease mechanisms is being overshadowed by human-centric studies and patient-derived models.
  5. Single Disease Focus Publications:
    There has been a waning interest in studies focusing solely on one specific neuromuscular disorder, as the journal increasingly seeks to address broader themes that encompass multiple disorders.

Similar Journals

CLINICAL ENDOCRINOLOGY

Your gateway to the latest in endocrinology excellence.
Publisher: WILEYISSN: 0300-0664Frequency: 12 issues/year

CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.

PRACTICAL NEUROLOGY

Transforming Neurological Research into Clinical Excellence
Publisher: BMJ PUBLISHING GROUPISSN: 1474-7758Frequency: 6 issues/year

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

Seminars in Pediatric Neurology

Enhancing pediatric neurology with critical research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1071-9091Frequency: 4 issues/year

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

Kidney Diseases

Empowering global collaboration in kidney research.
Publisher: KARGERISSN: 2296-9381Frequency: 6 issues/year

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.

Journal of Pediatric Neurology

Exploring innovative therapies for young minds.
Publisher: GEORG THIEME VERLAG KGISSN: 1304-2580Frequency: 6 issues/year

Journal of Pediatric Neurology, published by GEORG THIEME VERLAG KG, stands as a dedicated resource in the field of pediatric neurology, navigating the complex interplay of neurological and developmental disorders affecting children. With its ISSN 1304-2580 and E-ISSN 1875-9041, this journal has been a pivotal platform for advancing research since its inception in 2003, and continues to present critical findings and discussions up to 2024. Although currently categorized in the Q4 quartile for both Neurology (Clinical) and Pediatrics, Perinatology and Child Health within Scopus rankings, the journal's commitment to fostering scholarly dialogue is essential for researchers, clinicians, and students dealing with pediatric patients. Its structured coverage of various neurological disorders, treatment strategies, and innovative therapies contributes to the broader understanding of pediatric neurology, despite the challenges noted in its ranking percentile. By encouraging submissions from diverse disciplines, the journal aims to enhance clinical practice and bridge gaps in knowledge, ensuring a multidisciplinary approach to child health and development.

Neurology Research International

Connecting Researchers for a Brighter Neurological Future
Publisher: HINDAWI LTDISSN: 2090-1852Frequency:

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

KLINISCHE NEUROPHYSIOLOGIE

Unlocking the mysteries of neurological disorders.
Publisher: GEORG THIEME VERLAG KGISSN: 1434-0275Frequency: 4 issues/year

KLINISCHE NEUROPHYSIOLOGIE is a pivotal journal dedicated to advancing the field of clinical neurophysiology, published by GEORG THIEME VERLAG KG in Germany. With an ISSN of 1434-0275 and an E-ISSN of 1439-4081, this journal aims to disseminate high-quality research findings that enhance our understanding of neurological disorders and their physiological underpinnings. Although currently positioned in the fourth quartile in both Neurology (clinical) and Physiology (medical) categories, the journal offers a unique platform for novel insights and empirical studies, filling a crucial niche within the medical community. Researchers, healthcare professionals, and students can benefit from its Open Access option, which promotes wider accessibility and engagement with cutting-edge scientific discourse. As the journal converges through the years from 1998 to 2024, it remains committed to fostering scholarly collaboration and innovation in neurophysiological research, crucial for improving clinical outcomes.

Journal of Neuromuscular Diseases

Fostering collaboration for groundbreaking neuromuscular discoveries.
Publisher: IOS PRESSISSN: 2214-3599Frequency: 1 issue/year

Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.

Therapeutic Advances in Neurological Disorders

Exploring groundbreaking research in neurology.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-2856Frequency: 1 issue/year

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.

CURRENT OPINION IN NEUROLOGY

Exploring the Frontiers of Neurology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.